Skip navigation
Physician Notices and Updates

Vaccine Ordering Deadlines for Holiday Closure, Adult RSV Program Vaccine Updates and Men C-ACYW Product Change

Halton Region Public Health: Office of the Medical Officer of Health


Quick facts

  • Halton Region’s administrative offices will be closed from Wednesday, December 24, 2025, to Thursday, January 1, 2026, and will reopen on Friday, January 2, 2026.
  • Vaccine distribution will be unavailable during the closure.
  • Refer to the order cut-off dates and distribution schedule below to ensure your facility receives vaccines before the holiday closure.
  • Abrysvo™, was previously in limited supply and was prioritized for pregnant individuals. Additional supply has since been secured, and this product is now being distributed to support the Older Adult RSV Prevention Program.
  • Abrysvo™ can now be used for eligible older adults and pregnant people. Adult RSV vaccine orders will be fulfilled with either Abrysvo™ or Arexvy®, depending on availability at the PHU.
  • The Ontario Ministry of Health has indicated that MenQuadfi™ will replace Menactra® as the Men-C-ACYW-135 product beginning in early 2026.

Key information for healthcare providers

Please plan ahead and order enough vaccines to support your facility until the new year, taking available fridge space into consideration.

Holiday Vaccine Ordering Deadlines for South Halton

Order deadline Burlington delivery date Oakville delivery date Pick-up dates
December 17, 2025 December 23, 2025 December 22, 2025** December 22/23, 2025
January 6, 2026 January 13, 2026 January 14, 2026 January 13/14, 2026
 

**Note that delivery/pick up for Oakville is scheduled for Monday, December 22, 2025, instead of Wednesday, December 24, 2025.

Holiday Vaccine Ordering Deadlines for North Halton

Order deadline Milton delivery date Halton Hills delivery date Pick-up dates
December 10, 2025 December 16, 2025 December 16, 2025 December 16/17, 2025
December 31, 2025 January 6, 2026 January 6, 2026 January 6/7, 2026
 

Adult RSV Program Vaccine Update

  • Abrysvo™ and Arexvy® are the two publicly funded vaccines authorized by Health Canada for the prevention of RSV lower respiratory tract disease in adults 60 years of age and older.
  • The Health Unit has now received sufficient inventory of AbrysvoTM and will be fulfilling your Adult RSV orders with either Abrysvo™ or Arexvy® based on availability.
  • Abrysvo™ should no longer be reserved only for pregnant individuals. It can be administered to all adults that meet the eligibility criteria for the Infant and Adult RSV Prevention Program (external link).

Men C-ACYW Product Change

MenQuadfi™ will be replacing Menactra® as the Men C-ACYW product under the publicly funded immunization program in early 2026. Distribution to health care providers will begin as soon as the product is received from the Ministry of Health and our existing supply of Menactra has been fully distributed.

Additional resources

Back to Physician Notices and Updates
Top